Taiwan biotech industry growth strategy analysis:A Case Study of the Center pharmaceutical company
碩士 === 國立臺灣師範大學 === 高階經理人企業管理碩士在職專班(EMBA) === 103 === Using “Biotech and New Pharmaceutical Development Act "to provide tax incentives to technology, personnel and funding to encourage manufacturers to invest biotech drug development. As at the end of April 2014, there have been 70 new biotechn...
Main Authors: | Tai,Chung-Hui, 戴宗輝 |
---|---|
Other Authors: | Wang, Shih-Ju |
Format: | Others |
Language: | zh-TW |
Published: |
2015
|
Online Access: | http://ndltd.ncl.edu.tw/handle/24q7f7 |
Similar Items
-
The strategy for traditional foodstuff and pharmaceutical companies upgrading into biotech industry
by: Pei-Lei Liu, et al.
Published: (2002) -
The Study of the Legal Conditions of Biotech and New Pharmaceuticals Industry of Taiwan by Act for the Development of Biotech and New Pharmaceuticals Industry
by: Tor-Chern Chen, et al.
Published: (2010) -
Intellectual Capital and Financial Performance of Biotech Companies in the Pharmaceutical Industry
by: Ion Anghel, et al.
Published: (2018-08-01) -
Mergers and acquisitions in the pharmaceutical and biotech industries
by: Ireland, John M. (John Mathias), 1964-
Published: (2005) -
Strategic Valuation of Match Making Strategies between Biotech and Pharmaceutical Companies
by: Ching-Tien Su, et al.
Published: (2007)